AssetMark Inc
ELV icon

AssetMark Inc’s Elevance Health ELV Stock Holding History

AssetMark Inc’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.5M Buy
158,971
+13,446
+9% +$4.99M 0.11% 162
2026
Q1 		$42.6M Buy
145,525
+39,837
+38% +$13.1M 0.09% 187
2025
Q4 		$37M Buy
105,688
+18,913
+22% +$6.39M 0.08% 208
2025
Q3 		$28M Buy
86,775
+19,078
+28% +$5.93M 0.06% 245
2025
Q2 		$26.3M Buy
67,697
+25,933
+62% +$10.4M 0.06% 233
2025
Q1 		$18.2M Buy
41,764
+4,266
+11% +$1.71M 0.05% 260
2024
Q4 		$13.8M Buy
37,498
+25,363
+209% +$10.6M 0.04% 308
2024
Q3 		$6.31M Buy
12,135
+220
+2% +$118K 0.02% 417
2024
Q2 		$6.46M Sell
11,915
-737
-6% -$390K 0.02% 383
2024
Q1 		$6.56M Sell
12,652
-5,217
-29% -$2.59M 0.02% 368
2023
Q4 		$8.43M Buy
17,869
+362
+2% +$167K 0.03% 295
2023
Q3 		$7.62M Sell
17,507
-1,270
-7% -$576K 0.03% 283
2023
Q2 		$8.34M Buy
18,777
+599
+3% +$276K 0.03% 268
2023
Q1 		$8.36M Buy
18,178
+1,289
+8% +$613K 0.03% 258
2022
Q4 		$8.66M Buy
16,889
+1,152
+7% +$585K 0.04% 240
2022
Q3 		$7.15M Buy
15,737
+2,322
+17% +$1.11M 0.03% 245
2022
Q2 		$6.47M Buy
13,415
+5,171
+63% +$2.56M 0.03% 245
2022
Q1 		$4.05M Buy
8,244
+7,357
+829% +$3.36M 0.02% 278
2021
Q4 		$411K Buy
887
+268
+43% +$113K ﹤0.01% 576
2021
Q3 		$231K Buy
619
+102
+20% +$38.8K ﹤0.01% 553
2021
Q2 		$197K Buy
517
+18
+4% +$6.88K ﹤0.01% 576
2021
Q1 		$179K Sell
499
-32
-6% -$10.3K ﹤0.01% 569
2020
Q4 		$171K Sell
531
-52
-9% -$16K ﹤0.01% 566
2020
Q3 		$157K Sell
583
-78
-12% -$21K ﹤0.01% 542
2020
Q2 		$174K Sell
661
-5,806
-90% -$1.55M ﹤0.01% 511
2020
Q1 		$1.47M Buy
6,467
+1,086
+20% +$296K 0.01% 289
2019
Q4 		$1.63M Sell
5,381
-82,414
-94% -$22.7M 0.01% 321
2019
Q3 		$21.1M Buy
87,795
+3,352
+4% +$918K 0.18% 121
2019
Q2 		$23.8M Buy
84,443
+5,056
+6% +$1.38M 0.19% 112
2019
Q1 		$22.8M Buy
79,387
+2,983
+4% +$863K 0.21% 122
2018
Q4 		$20.1M Sell
76,404
-8,518
-10% -$2.34M 0.19% 113
2018
Q3 		$23.3M Sell
84,922
-1,005
-1% -$261K 0.21% 102
2018
Q2 		$20.5M Buy
85,927
+123
+0.1% +$28.5K 0.2% 107
2018
Q1 		$18.9M Sell
85,804
-21,860
-20% -$5.14M 0.2% 106
2017
Q4 		$24.2M Buy
107,664
+21,052
+24% +$4.48M 0.25% 100
2017
Q3 		$16.4M Buy
86,612
+84,190
+3,476% +$16M 0.19% 112
2017
Q2 		$456K Buy
2,422
+57
+2% +$10.2K 0.01% 354
2017
Q1 		$391K Buy
2,365
+2,128
+898% +$339K 0.01% 355
2016
Q4 		$34K Sell
237
-169
-42% -$22.6K ﹤0.01% 722
2016
Q3 		$51K Sell
406
-689
-63% -$89K ﹤0.01% 603
2016
Q2 		$144K Buy
1,095
+770
+237% +$105K ﹤0.01% 438
2016
Q1 		$45K Buy
325
+51
+19% +$6.82K ﹤0.01% 576
2015
Q4 		$38K Buy
+274
New +$37.7K ﹤0.01% 679

Other funds holding ELV

AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
HGIM
High Ground Investment Management London, United Kingdom $1.14B AUM 29.32% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $2.96B AUM 15.6% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

AssetMark Inc's ELV Position: Q2 2026 in Review

AssetMark Inc increased its Elevance Health (ELV) stake by 9.2% in Q2 2026, buying an estimated $4.99M and bringing the position to 158,971 shares worth $61.5M. The position accounts for 0.11% of the portfolio, ranked #162.

AssetMark Inc first reported a position in ELV in Q4 2015 and has held it in 43 quarters since. 637 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • AssetMark Inc held 158,971 shares of Elevance Health worth $61.5M as of Q2 2026.
  • AssetMark Inc bought 13,446 Elevance Health shares in Q2 2026, an estimated $4.99M.
  • Elevance Health made up 0.11% of AssetMark Inc's portfolio in Q2 2026, its #162 holding.
  • AssetMark Inc first reported a position in Elevance Health in Q4 2015 and has held it in 43 quarters since.
  • 637 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.